Question 1

What is this medicine for, and how does it work?

Accepted Answer

This is an alkylating antineoplastic drug. It works by forming cross-links with DNA to prevent cancer cell division. It is used to treat various types of cancer including melanoma and Hodgkin's lymphoma.

Question 2

When and how should this medicine be taken?

Accepted Answer

• For IV use only • Must be diluted before use • Give over 15-60 minutes

Question 3

When should this medicine not be used?

Accepted Answer

• Do not use during pregnancy • Do not use if you have severe kidney or liver disease • Do not use if you have low blood cell counts

Question 4

What precautions should be taken before using this medicine?

Accepted Answer

• Must be administered in a hospital setting • May cause severe pain if it leaks under the skin during injection • Can cause nausea and vomiting • May increase risk of other cancers • Regular blood tests needed

Question 5

Is it safe to use this medicine during pregnancy?

Accepted Answer

• Limited data available; • Potential risks to fetus; • Use only if clearly needed

Question 6

Can this medicine be used while breastfeeding?

Accepted Answer

• Must be administered in a hospital setting • May cause severe pain if it leaks under the skin during injection • Can cause nausea and vomiting • May increase risk of other cancers • Regular blood tests needed

Question 7

What should be done if a dose is missed?

Accepted Answer

• If you miss a dose, take it as soon as you remember. • However, if it's almost time for your next dose, skip the missed dose. • Never take two doses together. • For once-daily dosing: If you remember on the same day, take the dose. • Take your next dose at the regular time. • If you miss multiple doses, contact your doctor. • It's very important to take this medication at the correct time.

Question 8

What should be done in case of an overdose?

Accepted Answer

• Overdose symptoms: Severe vomiting, bone marrow suppression. • Treatment: Supportive care, anti-emetics.

Question 9

What should be done if side effects are experienced?

Accepted Answer

• Common side effects: Severe nausea, vomiting, low blood counts, injection site pain • What to do: Anti-nausea medicines; Regular blood tests; Report fever; Stop taking the medication and seek medical advice if any severe side effect or unusual symptoms occur.

Question 10

What medical indications are treated with Dacarbazine?

Accepted Answer

Dacarbazine (Alkylating Agents) is a pharmaceutical active substance. It is indicated for the treatment of Hodgkin's Disease, Metastatic Melanoma, Soft Tissue Sarcoma.

Question 11

What is the recommended dosage for Dacarbazine?

Accepted Answer

Standard adult dosage: Intravenous – 2-4.5 mg/kg (daily). Pediatric dosage: Intravenous – 150 mg/m² (once daily for 5 days). Always consult a registered physician for individualized dosage adjustments based on clinical assessment.

Question 12

Is Dacarbazine safe during pregnancy and breastfeeding?

Accepted Answer

Dacarbazine is classified under Pregnancy Category "C". Always consult your healthcare provider or OB/GYN before taking this medication during pregnancy or lactation.

Question 13

What are the common side effects of Dacarbazine?

Accepted Answer

**More than 10%**; Nausea (More than 90%);Vomiting(More than 90%);Injection site pain;Leukopenia;Thrombocytopenia; **1-10%**; Alopecia;Rash;Photosensitivity;Anorexia;Metallic taste;Flu-like syndrome; **Frequency Not Defi

Clinical Information	Administration Information
Indication: Metastatic melanoma Age: Adult	Dose: Intravenous – 2-4.5 mg/kg Frequency: daily Duration: for 10 days Note: repeat at 4-week intervals
Indication: Metastatic melanoma Age: Adult	Dose: Intravenous – 200-250 mg/m2 BSA Frequency: daily Duration: for 5 days Note: repeat at 3-week intervals

Clinical Information	Administration Information
Indication: Hodgkin's Disease Condition: With other antineoplastics, eg ABVD	Dose: Intravenous – 150 mg/m² Frequency: once daily for 5 days Duration: repeat every 4 weeks Note: Dosage dependent on protocol
Indication: Hodgkin's Disease Condition: With other antineoplastics, eg ABVD	Dose: Intravenous – 375 mg/m² Frequency: on Day 1 Duration: repeat every 15 days Note: Dosage dependent on protocol

Clinical Information	Administration Information
Condition: Renal Impairment Creatinine Clearance 46-60 mL/minute	Dose: Dose – 80% of regular dose Note: Renal Dose Adjustment
Condition: Renal Impairment Creatinine Clearance 31-45 mL/minute	Dose: Dose – 75% of regular dose Note: Renal Dose Adjustment

Drug Name	Risk Factors
Vaccines	Impairs immune response; possible infection after admin of live vaccines
CYP1A2 inhibitors (e.g. amiodarone, ciprofloxacin, fluvoxamine, ketoconazole, lomefloxacin, ofloxacin, rofecoxib)	Effect increased

Medicine Overview

Indication

What is this medicine for, and how does it work?

When and how should this medicine be taken?

When should this medicine not be used?

What precautions should be taken before using this medicine?

Is it safe to use this medicine during pregnancy?

Can this medicine be used while breastfeeding?

What should be done if a dose is missed?

What should be done in case of an overdose?

What should be done if side effects are experienced?

Adult Dose

Child Dose

Renal Dose

Drug Interaction

Disease Interaction

Pregnancy

Data Sources